Repligen
RGEN
Market capitalization of Repligen (RGEN)
Market cap: $9.24 Billion
As of May 2024 Repligen has a market cap of $9.24 Billion. This makes Repligen the world's 1726th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Repligen from 2001 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $9.24 B | -7.88% |
| 2023 | $10.03 B | 6.78% |
| 2022 | $9.40 B | -35.8% |
| 2021 | $14.64 B | 39.65% |
| 2020 | $10.48 B | 117.67% |
| 2019 | $4.81 B | 107.98% |
| 2018 | $2.31 B | 46.54% |
| 2017 | $1.58 B | 51.58% |
| 2016 | $1.04 B | 11.86% |
| 2015 | $0.93 B | 43.64% |
| 2014 | $0.64 B | 49.02% |
| 2013 | $0.43 B | 122.28% |
| 2012 | $0.19 B | 83.81% |
| 2011 | $0.10 B | -26.19% |
| 2010 | $0.14 B | 14.21% |
| 2009 | $0.12 B | 7.26% |
| 2008 | $0.11 B | -42.05% |
| 2007 | $0.20 B | 138.23% |
| 2006 | $85.38 M | -29.12% |
| 2005 | $0.12 B | 39.07% |
| 2004 | $86.61 M | -33.8% |
| 2003 | $0.13 B | 57.42% |
| 2002 | $83.11 M | 28.06% |
| 2001 | $64.9 M |
End of Day market cap according to different sources
On May 8th, 2024 the market cap of Repligen was reported to be:
$9.24 Billion
$9.24 Billion
$9.24 Billion
$9.24 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $160.19 B | 1,632.31% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $218.96 B | 2,267.87% | 🇺🇸 USA |
 General Electric GE | $184.83 B | 1,898.77% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $88.52 B | 857.27% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $0.10 B | -98.87% | 🇺🇸 USA |
 Novavax NVAX | $0.62 B | -93.21% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $13.99 B | 51.29% | 🇺🇸 USA |
 Bio-Techne TECH | $12.14 B | 31.30% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $15.53 B | 68.02% | 🇺🇸 USA |
 Charles River Laboratories
CRL | $12.11 B | 31.06% | 🇺🇸 USA |